Working and treatment of La indocin - indomethacin Prescription drug
|
|
|
|
|
|
| Working & Treatment of
Indocin - Indomethacin |
Indocin prepared by using active ingredient Indomethacin belongs to
the non-steroidal anti-inflammatory drug (NSAD) that has the
antipyretic and analgesic properties. The mechanism of Indocin like
other anti-inflammatory medications is yet unknown. Anyway, the
therapeutic action of Indocin is not due to pituitary-adrenal
stimulation. Indocin is believed to be the most effective inhibitor
of prostaglandin synthesis in vitro. Besides this, concentrations
are reached during the treatment which has shown affecting in vivo
also. Prostaglandins sensitize afferent nerves and effect the action
of bradykinin including pain in animals. Furthermore, prostaglandins
are believed to be among the mediators of inflammation and because
Indocin is the prostaglandin synthesis inhibitor, its mode of action
is supposed to be because of reduction of prostaglandins in
peripheral tissues.
Indocin-Indomethacin is proved to be the powerful anti-inflammatory
agent and is suitable for continued use in treating rheumatoid
arthritis, ankylosing spondylitis and osteoarthritis. Indocin gives
relief of symptoms and does not modify or change the progressive
course of the original ailments. This medication suppresses
inflammation in the rheumatoid arthritis as experienced by relief of
pain and lowering of fever, swelling and tenderness. The improvement
noticed in patients who have been treated with Indocin for
rheumatoid arthritis proved that they experienced relief in joint
swelling, average of numbers of joints affected and stiffness during
the mornings, the improved mobility as reported by the reduction in
walking time as well as the improved functional capability besides
improvement in their gripping strengths.
Indocin may enable decrease in steroid doses in patients undergoing
steroidal therapy for rather severe types of rheumatoid arthritis.
The drug has been reported to minimize basal and CO2 stimulated
cerebral blood flow in healthy volunteers following acute oral and
intravenous treatments.
|
|
|
|
|
